Etoricoxib-Induced Erythema-Multiforme-Like Eruption

Vol. 216, No. 3, 2008

Free Abstract Article (Fulltext) Article (PDF 168 KB)

Case Report

Etoricoxib-Induced Erythema-Multiforme-Like Eruption
Laurence Thirion, Arjen F. Nikkels, Gérald E. Piérard

Department of Dermatopathology, University Medical Center of Liège, Liège, Belgium

Address of Corresponding Author

Dermatology 2008;216:227-228 (DOI: 10.1159/000112930)

Key Words

Drug reaction
Etoricoxib
Erythema-multiforme-like eruption

Abstract

Etoricoxib is a new, highly selective cyclooxygenase (COX) 2 inhibitor, reported to have an increased cutaneous and systemic safety profile compared to the previous COX-2 inhibitors, including celecoxib, rofecoxib and valdecoxib. To the best of our knowledge, the present case of etoricoxib-induced erythema-multiforme-like eruption is the first reported in the literature.

Author Contacts

Dr. A.F. Nikkels, MD, PhD
Department of Dermatopathology
CHU du Sart-Tilman
BE-4000 Liège (Belgium)
Tel. +32 4 366 2499, Fax +32 4 366 2976, E-Mail af.nikkels@chu.ulg.ac.be

Article Information

Received: June 6, 2007
Accepted: July 24, 2007
Published online: January 9, 2008
Number of Print Pages : 2
Number of Figures : 2, Number of Tables : 0, Number of References : 11

Medline Abstract (ID 18182814)

Download Citation

Cited In

This journal is part of the fourth subject package of the Karger

Journal Archive Collection

Information on packages (PDF)
Free sample issues

For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service.